Article
HIV resistance: the new enemy.
Common factor (Stoughton, Mass.) - 1 Nov 1997
Colvin R
Abstract excerpt
HIV resistance continues to be a concern, particularly with the advent of potent anti-HIV therapies, i.e., protease inhibitors and non-nucleoside reverse transcriptase inhibitors. What is known about resistance to specific drugs and how to remain HIV-sensitive to various drugs are summarized. HIV resistance to nucleoside analogs, protease inhibitors, and non-nucleoside reverse transcriptase inhibitors is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
